Profile
Jeffery S.
Loutit was the founder and had founded Rempex Pharmaceuticals, Inc. in 2011, where he held the title of Chief Medical Officer from 2011 to 2013.
Dr. Loutit's former jobs include Vice President-Clinical Science at InterMune, Inc., Assistant Professor-Medicine at Stanford University, and Chief Medical Officer at MPEX Pharmaceuticals, Inc. Dr. Loutit received a doctorate degree from the University of Otago.
Former positions of Jeffery S. Loutit
| Companies | Position | End |
|---|---|---|
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers new antibacterial drugs | Founder | 01/12/2013 |
| INTERMUNE INC | Corporate Officer/Principal | - |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
MPEX Pharmaceuticals, Inc.
MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapies for antibiotic resistance | Chief Tech/Sci/R&D Officer | - |
Training of Jeffery S. Loutit
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Otago
University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MPEX Pharmaceuticals, Inc.
MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapies for antibiotic resistance | Commercial Services |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers new antibacterial drugs | Health Technology |
- Stock Market
- Insiders
- Jeffery S. Loutit
















